Dynamics of adrenal steroids are related to variations in Th1 and treg populations during mycobacterium tuberculosis infection in HIV positive persons

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Quiroga, Maria Florencia ^a   Angerami, Matias Tomas ^a   Santucci, Natalia ^b   Ameri, Diego ^c,d   Francos, Jose Luis ^e   Wallach, Jorge ^e   Sued, Omar ^c,d,f   Cahn, Pedro ^c,d   Salomón, Horacio ^a   Bottasso, Oscar ^b  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

^c HOSPITAL JUAN A FERNÁNDEZ   (Argentina)

^d Huesped Foundation   (Argentina)

^e FJ Muñiz Infectious Diseases Hospital   (Argentina)

^f PAN AMERICAN HEALTH ORGANIZATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; GAMMA INTERFERON; HYDROCORTISONE; INTERLEUKIN 2 RECEPTOR ALPHA; PRASTERONE; PRASTERONE SULFATE; TRANSCRIPTION FACTOR FOXP3; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; STEROID;

ADAPTIVE IMMUNITY; ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CD4+ CD25+ T LYMPHOCYTE; CELL FUNCTION; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; IMMUNE RESPONSE; IMMUNOREGULATION; INNATE IMMUNITY; LATENT TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MYCOBACTERIUM TUBERCULOSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; TH1 CELL; TUBERCULOSIS; ADRENAL GLAND; BLOOD; DRUG EFFECT; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; MIDDLE AGED; PHYSIOLOGY;

MYCOBACTERIUM TUBERCULOSIS;

ADRENAL GLANDS; ADULT; COINFECTION; DEHYDROEPIANDROSTERONE; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HIV INFECTIONS; HUMANS; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; INTERFERON-GAMMA; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; STEROIDS; T-LYMPHOCYTES, REGULATORY; TH1 CELLS; TUBERCULOSIS;

EID: 84858224454     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0033061     Document Type: Article

References (49)

1. WHO, (2009) Global tuberculosis control: a short update to the 2009 report. WHO Report 2009. Geneva, Switzerland WHO Press.
2. Rook GA, Hernandez-Pando R, (1994) T cell helper types and endocrines in the regulation of tissue-damaging mechanisms in tuberculosis. Immunobiology 191: 478-492.
3. Lawn SD, Zumla AI, (2011) Tuberculosis. Lancet 378: 57-72.
4. Cardona PJ, (2010) Revisiting the natural history of tuberculosis. The inclusion of constant reinfection, host tolerance, and damage-response frameworks leads to a better understanding of latent infection and its evolution towards active disease. Arch Immunol Ther Exp (Warsz) 58: 7-14.
5. Guihot A, Bourgarit A, Carcelain G, Autran B, (2011) Immune reconstitution after a decade of combined antiretroviral therapies for human immunodeficiency virus. Trends Immunol 32: 131-137.
6. Calligaro G, Meintjes G, Mendelson M, (2011) Pulmonary manifestations of the immune reconstitution inflammatory syndrome. Curr Opin Pulm Med 17: 180-188.
7. Lawn SD, Bekker LG, Miller RF, (2005) Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals. Lancet Infect Dis 5: 361-373.
8. Meintjes G, Lawn SD, Scano F, Maartens G, French MA, et al. (2008) Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings. Lancet Infect Dis 8: 516-523.
9. Bourgarit A, Carcelain G, Martinez V, Lascoux C, Delcey V, et al. (2006) Explosion of tuberculin-specific Th1-responses induces immune restoration syndrome in tuberculosis and HIV co-infected patients. Aids 20: F1-7.
10. Meintjes G, Wilkinson KA, Rangaka MX, Skolimowska K, van Veen K, et al. (2008) Type 1 helper T cells and FoxP3-positive T cells in HIV-tuberculosis-associated immune reconstitution inflammatory syndrome. Am J Respir Crit Care Med 178: 1083-1089.
11. Fabri M, Stenger S, Shin DM, Yuk JM, Liu PT, et al. (2011) Vitamin D is required for IFN-gamma-mediated antimicrobial activity of human macrophages. Sci Transl Med 3: 104ra102.
12. Rey AD, Mahuad CV, Bozza VV, Bogue C, Farroni MA, et al. (2007) Endocrine and cytokine responses in humans with pulmonary tuberculosis. Brain Behav Immun 21: 171-179.
13. Bottasso O, Bay ML, Besedovsky H, del Rey A, (2007) The immuno-endocrine component in the pathogenesis of tuberculosis. Scand J Immunol 66: 166-175.
14. Dillon JS, (2005) Dehydroepiandrosterone, dehydroepiandrosterone sulfate and related steroids: their role in inflammatory, allergic and immunological disorders. Curr Drug Targets Inflamm Allergy 4: 377-385.
15. Loria RM, (2009) Beta-androstenes and resistance to viral and bacterial infections. Neuroimmunomodulation 16: 88-95.
16. Rainey WE, Carr BR, Sasano H, Suzuki T, Mason JI, (2002) Dissecting human adrenal androgen production. Trends Endocrinol Metab 13: 234-239.
17. Reading C, Dowding C, Schramm B, Garsd A, Onizuka-Handa N, et al. (2006) Improvement in immune parameters and human immunodeficiency virus-1 viral response in individuals treated with 16alpha-bromoepiandrosterone (HE2000). Clin Microbiol Infect 12: 1082-1088.
18. Stickney DR, Noveljic Z, Garsd A, Destiche DA, Frincke JM, (2007) Safety and activity of the immune modulator HE2000 on the incidence of tuberculosis and other opportunistic infections in AIDS patients. Antimicrob Agents Chemother 51: 2639-2641.
19. Hernandez-Pando R, Aguilar-Leon D, Orozco H, Serrano A, Ahlem C, et al. (2005) 16alpha-Bromoepiandrosterone restores T helper cell type 1 activity and accelerates chemotherapy-induced bacterial clearance in a model of progressive pulmonary tuberculosis. J Infect Dis 191: 299-306.
20. Cooper AM, (2009) T cells in mycobacterial infection and disease. Curr Opin Immunol 21: 378-384.
21. Chen X, Zhou B, Li M, Deng Q, Wu X, et al. (2007) CD4(+)CD25(+)FoxP3(+) regulatory T cells suppress Mycobacterium tuberculosis immunity in patients with active disease. Clin Immunol 123: 50-59.
22. Seddiki N, Sasson SC, Santner-Nanan B, Munier M, van Bockel D, et al. (2009) Proliferation of weakly suppressive regulatory CD4+ T cells is associated with over-active CD4+ T-cell responses in HIV-positive patients with mycobacterial immune restoration disease. Eur J Immunol 39: 391-403.
23. OARAC, (2011) Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Available: http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf, editor.
24. Turk G, Gherardi MM, Laufer N, Saracco M, Luzzi R, et al. (2008) Magnitude, breadth, and functional profile of T-cell responses during human immunodeficiency virus primary infection with B and BF viral variants. J Virol 82: 2853-2866.
25. Bozza VV, D'Attilio L, Mahuad CV, Giri AA, del Rey A, et al. (2007) Altered cortisol/DHEA ratio in tuberculosis patients and its relationship with abnormalities in the mycobacterial-driven cytokine production by peripheral blood mononuclear cells. Scand J Immunol 66: 97-103.
26. Araghi-Niknam M, Liang B, Zhang Z, Ardestani SK, Watson RR, (1997) Modulation of immune dysfunction during murine leukaemia retrovirus infection of old mice by dehydroepiandrosterone sulphate (DHEAS). Immunology 90: 344-349.
27. Bi X, Suzuki Y, Gatanaga H, Oka S, (2009) High frequency and proliferation of CD4+ FOXP3+ Treg in HIV-1-infected patients with low CD4 counts. Eur J Immunol 39: 301-309.
28. Garg A, Barnes PF, Roy S, Quiroga MF, Wu S, et al. (2008) Mannose-capped lipoarabinomannan- and prostaglandin E2-dependent expansion of regulatory T cells in human Mycobacterium tuberculosis infection. Eur J Immunol 38: 459-469.
29. Xiang L, Marshall GD Jr, (2011) Immunomodulatory effects of in vitro stress hormones on FoxP3, Th1/Th2 cytokine and costimulatory molecule mRNA expression in human peripheral blood mononuclear cells. Neuroimmunomodulation 18: 1-10.
30. Christeff N, Gherbi N, Mammes O, Dalle MT, Gharakhanian S, et al. (1997) Serum cortisol and DHEA concentrations during HIV infection. Psychoneuroendocrinology 22 (Suppl 1): S11-18.
31. Hennebold JD, Daynes RA, (1994) Regulation of macrophage dehydroepiandrosterone sulfate metabolism by inflammatory cytokines. Endocrinology 135: 67-75.
32. Boulware DR, Hullsiek KH, Puronen CE, Rupert A, Baker JV, et al. (2011) Higher Levels of CRP, D-dimer, IL-6, and Hyaluronic Acid Before Initiation of Antiretroviral Therapy (ART) Are Associated With Increased Risk of AIDS or Death. J Infect Dis 203: 1637-1646.
33. Van den Berghe G, (2003) Endocrine evaluation of patients with critical illness. Endocrinol Metab Clin North Am 32: 385-410.
34. Besedovsky HO, del Rey A, (1996) Immune-neuro-endocrine interactions: facts and hypotheses. Endocr Rev 17: 64-102.
35. Elenkov IJ, Chrousos GP, (1999) Stress Hormones, Th1/Th2 patterns, Pro/Anti-inflammatory Cytokines and Susceptibility to Disease. Trends Endocrinol Metab 10: 359-368.
36. Rook GA, Dheda K, Zumla A, (2005) Immune responses to tuberculosis in developing countries: implications for new vaccines. Nat Rev Immunol 5: 661-667.
37. Sakaguchi S, Miyara M, Costantino CM, Hafler DA, (2010) FOXP3+ regulatory T cells in the human immune system. Nat Rev Immunol 10: 490-500.
38. Rudensky AY, (2011) Regulatory T cells and Foxp3. Immunol Rev 241: 260-268.
39. Ribeiro-Rodrigues R, Resende Co T, Rojas R, Toossi Z, Dietze R, et al. (2006) A role for CD4+CD25+ T cells in regulation of the immune response during human tuberculosis. Clin Exp Immunol 144: 25-34.
40. Toossi Z, Hirsch CS, Wu M, Mayanja-Kizza H, Baseke J, et al. (2011) Distinct cytokine and regulatory T cell profile at pleural sites of dual HIV/tuberculosis infection compared to that in the systemic circulation. Clin Exp Immunol 163: 333-338.
41. Guyot-Revol V, Innes JA, Hackforth S, Hinks T, Lalvani A, (2006) Regulatory T cells are expanded in blood and disease sites in patients with tuberculosis. Am J Respir Crit Care Med 173: 803-810.
42. Horwitz DA, (2010) Identity of mysterious CD4+CD25-Foxp3+ cells in SLE. Arthritis Res Ther 12: 101.
43. Yang HX, Zhang W, Zhao LD, Li Y, Zhang FC, et al. (2009) Are CD4+CD25-Foxp3+ cells in untreated new-onset lupus patients regulatory T cells? Arthritis Res Ther 11: R153.
44. Bonelli M, Savitskaya A, Steiner CW, Rath E, Smolen JS, et al. (2009) Phenotypic and functional analysis of CD4+ CD25- Foxp3+ T cells in patients with systemic lupus erythematosus. J Immunol 182: 1689-1695.
45. Gavin MA, Torgerson TR, Houston E, DeRoos P, Ho WY, et al. (2006) Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development. Proc Natl Acad Sci U S A 103: 6659-6664.
46. Bianchini R, Bistoni O, Alunno A, Petrillo MG, Ronchetti S, et al. (2011) CD4(+) CD25(low) GITR(+) cells: a novel human CD4(+) T-cell population with regulatory activity. Eur J Immunol 41: 2269-2278.
47. Karagiannidis C, Akdis M, Holopainen P, Woolley NJ, Hense G, et al. (2004) Glucocorticoids upregulate FOXP3 expression and regulatory T cells in asthma. J Allergy Clin Immunol 114: 1425-1433.
48. Coles AJ, Thompson S, Cox AL, Curran S, Gurnell EM, et al. (2005) Dehydroepiandrosterone replacement in patients with Addison's disease has a bimodal effect on regulatory (CD4+CD25hi and CD4+FoxP3+) T cells. Eur J Immunol 35: 3694-3703.
49. Perez AR, Bottasso O, Savino W, (2009) The impact of infectious diseases upon neuroendocrine circuits. Neuroimmunomodulation 16: 96-105.